欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/1119/001
药品名称Naloxone Accord 0,4 mg/ml
活性成分
    • NALOXONE HYDROCHLORIDE dihydrate 0.4 mg/ml
剂型Solution for injection in pre-filled syringe
上市许可持有人Accord Healthcare B.V. Winthontlaan 200 3526 KV UTRECHT Netherlands
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Germany (DE)
      Naloxone Accord 0.4 mg/ml Injektions-/Infusionslösung in einer Fertigspritze
    • Poland (PL)
      Naloxone Accord
    • Denmark (DK)
    • Czechia (CZ)
      Naloxone Accord
    • Belgium (BE)
      Naloxone Accord 0,4 mg/ml Solution injectable/pour perfusion en seringue préremplie
    • Netherlands (NL)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
许可日期2022/12/22
最近更新日期2024/04/09
药物ATC编码
    • V03AB15 naloxone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase